Emeis Stock: Significant Rebound Following the Announcement of an Accelerated Safeguard Plan Exit
Emeis stock significantly advanced this Wednesday, February 25, driven by the positive momentum following the announcement of an early exit from the accelerated safeguard plan. The stock is trading at 14.51 euros, up 2.04% from the previous day. This rebound comes after a week of nearly 5% decline, in the context of completed restructuring for the healthcare services group.
The major event driving the stock this week remains the announcement on Sunday, February 23, of Emeis's early exit from the accelerated safeguard plan, approved by the Nanterre Court of Economic Affairs as early as February 20. This milestone concludes three years of restructuring for the group specializing in health services and support for dependent individuals. Over one year, Emeis's stock performance reached 50.13%, reflecting the recovery trajectory embarked upon since the crisis the group went through. The next financial meeting is scheduled for April 7, 2026, when the company will publish its annual results for the fiscal year 2025. These figures will allow for an evaluation of the concrete effects of the restructuring on the group's fundamentals and the durability of its operational model.
Technical Analysis Shows Positive Trend
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
From a technical perspective, the current price of 14.51 euros is above the 50-day moving average, set at 14.03 euros, indicating a favorable short-term trend. This positive gap is even more pronounced compared to the 200-day moving average, which stands at 12.90 euros, confirming the medium-term bullish momentum of the stock. The RSI, an indicator measuring the relative strength of the ongoing movement, is at 52, a neutral level indicating neither overbought nor oversold conditions. The nearest resistance is at 15.49 euros: crossing this threshold could potentially open the way for a new phase of appreciation. In the short term, the 8.61% progress over three months illustrates the stock's upward trajectory, although the nearly 5% weekly correction suggests that the upcoming sessions should be watched carefully.
SectorServices et infrastructure de santé›Etablissements de santé / EHPAD
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: 9M 2026
Key reported figures
Revenue: 4 543 millions d'euros
Quarterly revenue: 4 543 millions d'euros
Revenue growth: 3,5 %
Guidance from the release
« Les tendances observées lors des 9 premiers mois de l'année 2026 confortent emeis dans l'atteinte des objectifs pour 2026, objectifs par ailleurs relevés fin juillet. »
Risks mentioned
Health crises linked to flu outbreaks and heat waves requiring proactive management
Macroeconomic uncertainty and risk of return to inflation impacting operating expenses
Dependency on continued execution of operational efficiency programs such as the Boost initiative in France
Opportunities identified
Strong like-for-like revenue growth of +6.0% driven by improved occupancy rates and favorable pricing effects
Average occupancy rate now above 90% with +2.9 pts annual increase, particularly strong in nursing homes (+3.1 pts)
Structural demographic tailwind with European senior population aged 85+ expected to grow over 30% in next 10 years
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.